Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice. [electronic resource]
Producer: 20140930Description: 26-36 p. digitalISSN:- 1521-7035
- Animals
- Antineoplastic Agents -- pharmacology
- Brain Neoplasms -- therapy
- CD8-Positive T-Lymphocytes -- transplantation
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cell- and Tissue-Based Therapy
- Female
- Flow Cytometry
- Glioma -- therapy
- Immunotherapy, Adoptive
- Lipoproteins -- pharmacology
- Mice
- Mice, Inbred C57BL
- Polymerase Chain Reaction
- Toll-Like Receptor 1 -- agonists
- Toll-Like Receptor 2 -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.